title: The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing board.
authors.affiliation: Department of Internal Medicine, University of Nevada School of Medicine, Saint Mary's Regional Medical Center, 645 North Arlington Street, Reno, NV 89503, USA. mbloch@aol.com
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Bloch
authors.forename: Jan N
authors.initials: JN
authors.lastname: Basile
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017704:Baroreflex; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000473:pathology*; D011311:Pressoreceptors / Q000473:pathology*; D017211:Treatment Failure
chemical_list: D000959:Antihypertensive Agents